FDA OKs First Blood Test For Alzheimer’s Detection

UNITED STATES – For the first time, the Food and Drug Administration (FDA) has approved a blood test to help detect Alzheimer’s disease.

The test, for patients 55 and older showing symptoms, measures protein levels in the blood linked to signs of the disease, offering a less invasive option than costly brain scans or spinal taps.

It’s not a stand-alone diagnostic tool but doctors say it’s a major step toward faster, easier diagnoses.

With Alzheimer’s cases expected to double by 2060, experts say early detection is more critical than ever.